SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-021281
Filing Date
2023-08-01
Accepted
2023-07-31 21:47:35
Documents
99
Period of Report
2022-12-31
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K acrx20230717_8k.htm   iXBRL 8-K 37877
2 EXHIBIT 23 ex_544966.htm EX-23 2990
3 EXHIBIT 99.1 ex_544964.htm EX-99.1 171164
4 EXHIBIT 99.2 ex_544965.htm   iXBRL EX-99.2 1449124
  Complete submission text file 0001437749-23-021281.txt   10829948

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA acrx-20221231.xsd EX-101.SCH 106099
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20221231_cal.xml EX-101.CAL 80866
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20221231_def.xml EX-101.DEF 718839
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20221231_lab.xml EX-101.LAB 624323
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20221231_pre.xml EX-101.PRE 759161
93 EXTRACTED XBRL INSTANCE DOCUMENT acrx20230717_8k_htm.xml XML 1898412
Mailing Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545
Business Address 25821 INDUSTRIAL BOULEVARD SUITE 400 HAYWARD CA 94545 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35068 | Film No.: 231129368
SIC: 2834 Pharmaceutical Preparations